Price T Rowe Associates Inc Amneal Pharmaceuticals, Inc. Transaction History
Price T Rowe Associates Inc
- $812 Billion
- Q1 2025
A detailed history of Price T Rowe Associates Inc transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 126,676 shares of AMRX stock, worth $923,468. This represents 0.0% of its overall portfolio holdings.
Number of Shares
126,676
Previous 97,250
30.26%
Holding current value
$923,468
Previous $771,000
37.74%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding AMRX
# of Institutions
244Shares Held
137MCall Options Held
302KPut Options Held
103K-
Vanguard Group Inc Valley Forge, PA15.8MShares$115 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$89.9 Million3.16% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$82.2 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$78.3 Million2.58% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il7.49MShares$54.6 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.1B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...